Can Alexion Pharamaceuticals See an Upside Breakout?

 | Jul 17, 2017 | 3:38 PM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:


Alexion Pharamaceuticals, Inc. (ALXN) was upgraded today by TheStreet's Quant Ratings service. This might be just the thing to get the price of ALXN to make an upside breakout.

In this daily bar chart of ALXN, below, we can see that if we ignore or downplay a May/June selloff and rebound that prices have been in a largely sideways trading pattern for much of the past 12 months. In the past few weeks ALXN rallied above the bottoming 200-day moving average and the flattening 50-day average line.

The On-Balance-Volume (OBV) line has been in a downward trend from early January but has shown some improvement since late May. The MACD (Moving Average Convergence Divergence) oscillator turned positive in June.

In this weekly chart, below, we can see how ALXN has been trading above the declining 40-week moving average line. Closes above $130 and above $140 should strengthen the picture. The heavy weekly volume in May could have been a selling climax. The weekly MACD oscillator has crossed to the upside below the zero line for a cover shorts buy signal.

In this Point and Figure chart, below, we can see an upside price target of $147. Strength to $131.30 will help the bulls.

Bottom line: A quantitative upgrade and an evolving chart pattern could give ALXN shares a boost.

Columnist Conversations

As far as TSLA is concerned, I still have a higher target above the market at the 409 area.  I stated in ...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it violated the recent l...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after opening the session with a...



News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.